OMNICELL INC
For the period ended Dec 31, 2023. Filed Feb 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 28, 2024
OMCL$35.90-3.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Financial Statement Schedule II: Valuation and Qualifying Accounts F-
SCHEDULE II
VALUATION AND QUALIFYING ACCOUNTS
| Balance atBeginning of Period (1) · Charged (Credited) toCosts and Expenses (2) · AmountsWritten Off (3) · Other Adjustments (4) · Balance atEnd of Period (1) | ||||||
|---|---|---|---|---|---|---|
| (In thousands) | ||||||
| Accounts receivable and unbilled receivables | $4,286 | $2,130 | $(2,079) | $935 | $5,272 | |
| Long-term unbilled receivables | 30 | (4) | — | — | 26 | |
| Net investment in sales-type leases | 265 | (37) | — | — | 228 | |
| Total allowances deducted from assets | $4,581 | $2,089 | $(2,079) | $935 | $5,526 | |
| Accounts receivable and unbilled receivables | $5,272 | $2,658 | $(2,551) | $(226) | $5,153 | |
| Long-term unbilled receivables | 26 | 9 | — | — | 35 | |
| Net investment in sales-type leases | 228 | 80 | — | — | 308 | |
| Total allowances deducted from assets | $5,526 | $2,747 | $(2,551) | $(226) | $5,496 | |
| Accounts receivable and unbilled receivables | $5,153 | $2,726 | $(2,441) | $126 | $5,564 | |
| Long-term unbilled receivables | 35 | (4) | — | 31 | ||
| Net investment in sales-type leases | 308 | (51) | — | — | 257 | |
| Total allowances deducted from assets | $5,496 | $2,671 | $(2,441) | $126 | $5,852 | |
(1)Allowance for credit losses.
(2)Represents amounts charged and credited for provisions for credit losses.
(3)Represents amounts written off from the allowance and receivable.
(4)Represents other adjustments, such as foreign currency translation and purchase price accounting adjustments in connection with acquisitions.
INDEX TO EXHIBITS
| Incorporated By Reference | ||||
|---|---|---|---|---|
| Exhibit Number | Exhibit Description | Form | Exhibit | Filing Date |
| 2.1 | Securities Purchase Agreement, dated October 29, 2015, by and among Omnicell International, Inc., Omnicell, Inc., Aesynt Holding, L.P., Aesynt, Ltd., and Aesynt Holding Coöperatief U.A. | 8-K | 2.1 | 10/29/2015 |
| 2.2 | Stock Purchase Agreement, dated November 28, 2016, among Omnicell, Inc., Ateb, Inc., Ateb Canada Ltd., the related stockholders and optionholders, and the stockholders’ agent | 8-K | 2.1 | 11/29/2016 |
| 2.3 | Equity Purchase Agreement, dated August 11, 2020, by and among Omnicell, Inc., PSGH, LLC, BW Apothecary Holdings, LLC, the sellers identified therein and the sellers’ representative | 8-K | 2.1 | 8/12/2020 |
| 2.4 | Amendment No. 1, dated October 1, 2020, to Equity Purchase Agreement, by and among Omnicell, Inc. and the sellers’ representative | 10-Q | 2.2 | 10/30/2020 |
| 3.1 | Amended and Restated Certificate of Incorporation of Omnicell, Inc. | 8-K | 3.1 | 9/20/2001 |
| 3.2 | Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Omnicell, Inc. | 10-Q | 3.2 | 8/9/2010 |
| 3.3 | Certificate of Designation of Series A Junior Participating Preferred Stock | 10-K | 3.2 | 3/28/2003 |
| 3.4 | Third Amended and Restated Bylaws of Omnicell, Inc. | 8-K | 3.1 | 10/21/2022 |
| 4.1 | Reference is made to Exhibits 3.1, 3.2, 3.3, and 3.4 | |||
| 4.2 | Form of Common Stock Certificate | S-1/A | 4.1 | 7/24/2001 |
| 4.3 | Description of Omnicell, Inc.’s Securities Registered Pursuant to Section 12 of the Exchange Act | 10-K | 4.7 | 2/26/2020 |
| 4.4 | Indenture, dated as of September 25, 2020, by and between Omnicell, Inc. and U.S. Bank National Association, as Trustee | 8-K | 4.1 | 9/25/2020 |
| 4.5 | Form of Global Note, representing Omnicell, Inc.’s 0.25% Convertible Senior Notes due 2025 (included as Exhibit A to the Indenture filed as Exhibit 4.4) | 8-K | 4.2 | 9/25/2020 |
| 10.1* | Omnicell, Inc Amended and Restated 1997 Employee Stock Purchase Plan, as amended | S-8 | 99.1 | 5/26/2023 |
| 10.2* | Omnicell, Inc. 2009 Equity Incentive Plan, as amended | S-8 | 99.2 | 5/26/2023 |
| 10.3* | Form of Restricted Stock Unit Award Agreement for the 2009 Equity Incentive Plan, as amended | 10-Q | 10.4 | 8/9/2012 |
| 10.4* | Form of Performance Cash Award Grant Notice and Form of Performance Cash Award Agreement for the 2009 Equity Incentive Plan, as amended | 10-Q | 10.5 | 8/9/2012 |
| 10.5* | Form of Restricted Stock Bonus Grant Notice and Form of Restricted Stock Bonus Agreement for 2009 Equity Incentive Plan, as amended | S-8 | 99.4 | 5/24/2018 |
| 10.6* | Form of Option Grant Notice and Form of Option Agreement for 2009 Equity Incentive Plan, as amended | 8-K | 10.1 | 3/8/2019 |
| 10.7* | Form of Option Grant Notice and Form of Global Option Agreement for 2009 Equity Incentive Plan, as amended | 10-Q | 10.1 | 7/31/2020 |
| 10.8* | Form of Restricted Stock Unit Grant Notice and Form of Global Restricted Stock Unit Award Agreement for 2009 Equity Incentive Plan, as amended (July 2020) | 10-K | 10.9 | 2/24/2021 |
| 10.9* | Form of Restricted Stock Unit Grant Notice and Form of Global Restricted Stock Unit Award Agreement for 2009 Equity Incentive Plan, as amended (February 2021) | 10-K | 10.10 | 2/24/2021 |
| 10.10* | Omnicell, Inc. 2010 Quarterly Executive Bonus Plan | 8-K | 10.1 | 3/17/2010 |
| Incorporated By Reference | ||||
|---|---|---|---|---|
| Exhibit Number | Exhibit Description | Form | Exhibit | Filing Date |
| 10.11* | Offer letter between Omnicell, Inc. and Peter J. Kuipers dated August 11, 2015 | 10-Q | 10.3 | 11/6/2015 |
| 10.12* | Offer Letter between Omnicell, Inc. and Scott P. Seidelmann, dated March 29, 2018 | 10-K | 10.41 | 2/27/2019 |
| 10.13* | Offer letter between Omnicell, Inc. and Christine Mellon dated February 12, 2021 | 10-K | 10.32 | 2/25/2022 |
| 10.14 | Lease Agreement, dated December 21, 2001, by and between TC Northeast Metro, Inc. and Aesynt Incorporated (formerly McKesson Automation Inc.) | 10-Q | 10.3 | 5/6/2016 |
| 10.15 | First Amendment to Lease, dated April 8, 2005, by and between Multi-Employer Property Trust and Aesynt Incorporated (formerly McKesson Automation Inc.) | 10-K | 10.24 | 2/24/2021 |
| 10.16 | Second Amendment to Lease, dated April 21, 2008, by and between NewTower Trust Company Multi-Employer Property Trust and Aesynt Incorporated (formerly McKesson Automation Inc.) | 10-K | 10.25 | 2/24/2021 |
| 10.17 | Third Amendment to Lease, dated January 11, 2011, between Cranberry Cochran Road, L.P., et al. and Aesynt Incorporated (formerly McKesson Automation Inc.) | 10-K | 10.26 | 2/24/2021 |
| 10.18 | Fourth Amendment to Lease, dated October 29, 2013, between McKnight Cranberry III, L.P. and Aesynt Incorporated (formerly McKesson Automation Inc.) | 10-K | 10.27 | 2/24/2021 |
| 10.19 | Fifth Amendment to Lease, dated April 28, 2017, between McKnight Cranberry III, L.P. and Aesynt Incorporated | 10-Q | 10.3 | 5/5/2017 |
| 10.20 | Sixth Amendment to Lease, dated November 11, 2019, between McKnight Cranberry III, L.P. and Aesynt Incorporated | 10-K | 10.39 | 2/26/2020 |
| 10.21 | Form of Convertible Note Hedge Confirmation | 8-K | 10.1 | 9/25/2020 |
| 10.22 | Form of Warrant Confirmation | 8-K | 10.2 | 9/25/2020 |
| 10.23* | Promotion letter between Omnicell, Inc. and Corey J. Manley dated May 18, 2022 | 10K | 10.31 | 03/01/2023 |
| 10.24* | Offer Letter between Omnicell, Inc. and Nchacha E. Etta dated April 30, 2023 | 10Q | 10.3 | 08/04/2023 |
| 10.25* | Form of Option Grant Notice and Form of Global Option Agreement for 2009 Equity Incentive Plan, as amended (May 2023) | 10Q | 10.4 | 08/04/2023 |
| 10.26* | Omnicell, Inc. Executive Severance Plan | 10Q | 10.1 | 11/03/2023 |
| 10.27* | Separation Agreement dated August 4, 2023 by and between Omnicell, Inc. and Peter J. Kuipers | 10Q | 10.2 | 11/03/2023 |
| 10.28* | Form of Restricted Stock Unit Notice and Form of Global Restricted Stock Unit Award Agreement for 2009 Equity Incentive Plan, as amended (August 2023) | 10Q | 10.3 | 11/03/2023 |
| 10.29* | Separation Agreement dated October 4, 2023 by and between Omnicell, Inc. and Christine M. Mellon | 10Q | 10.4 | 11/03/2023 |
| 10.30 | Second Amended and Restated Credit Agreement, dated as of October 10, 2023, among Omnicell, Inc., the lenders party thereto, and Wells Fargo Bank, National Association, as administrative agent | 8-K | 10.1 | 10/16/2023 |
| 10.31* | Separation Agreement dated November 3, 2023 by and between Omnicell, Inc. and Scott P. Seidelmann | 8-K | 10.1 | 11/09/2023 |
| 10.32*+ | Form of Director and Officer Indemnity Agreement | |||
| 21.1+ | Subsidiaries of the Registrant | |||
| 23.1+ | Consent of Independent Registered Public Accounting Firm | |||
| Incorporated By Reference | ||||
| Exhibit Number | Exhibit Description | Form | Exhibit | Filing Date |
| 24.1+ | Power of Attorney (included on the signature pages hereto) | |||
| 31.1+ | Certification of Chief Executive Officer, as required by Rule 13a-14(a) or Rule 15d-14(a) | |||
| 31.2+ | Certification of Chief Financial Officer, as required by Rule 13a-14(a) or Rule 15d-14(a) | |||
| 32.1+ | Certification of Chief Executive Officer and Chief Financial Officer, as required by Rule 13a-14(b) or Rule 15d-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. §1350) | |||
| 97.1+ | Compensation Clawback Policy | |||
| 101.INS+ | Inline XBRL Instance Document - The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | |||
| 101.SCH+ | Inline XBRL Taxonomy Extension Schema Document | |||
| 101.CAL+ | Inline XBRL Taxonomy Extension Calculation Linkbase Document | |||
| 101.DEF+ | Inline XBRL Taxonomy Extension Definition Linkbase Document | |||
| 101.LAB+ | Inline XBRL Taxonomy Extension Labels Linkbase Document | |||
| 101.PRE+ | Inline XBRL Taxonomy Extension Presentation Linkbase Document | |||
| 104+ | Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101). | |||
- Indicates a management contract, compensation plan, or arrangement.
+Filed herewith.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.